Home/Filings/4/0001235802-20-000020
4//SEC Filing

PAUL AMY S 4

Accession 0001235802-20-000020

CIK 0001492658other

Filed

Mar 10, 8:00 PM ET

Accepted

Mar 11, 4:05 PM ET

Size

7.6 KB

Accession

0001235802-20-000020

Insider Transaction Report

Form 4
Period: 2020-03-10
PAUL AMY S
Director
Transactions
  • Exercise/Conversion

    Stock Option (right to buy)

    2020-03-1010,3090 total
    Exercise: $17.82Exp: 2020-05-13Ordinary Shares (10,309 underlying)
  • Exercise/Conversion

    Ordinary Shares, par value EUR 0.03 per share

    2020-03-10$17.82/sh+10,309$183,70659,889 total
Footnotes (4)
  • [F1]The reporting person exercised this option because the option was in the money and scheduled to expire on May 13, 2020.
  • [F2]Amount reflects the cancellation of 19 ordinary shares underlying a restricted stock unit award in lieu of Board committee retainers due to a change in Board committee memberships.
  • [F3]Includes 3,916 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan.
  • [F4]This option has fully vested.

Issuer

Wright Medical Group N.V.

CIK 0001492658

Entity typeother

Related Parties

1
  • filerCIK 0001235355

Filing Metadata

Form type
4
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 4:05 PM ET
Size
7.6 KB